Search

Kamal M Al-Shami,1,2,* Wesam S Ahmed,3,* Karem H Alzoubi1 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 22110, Jordan; 2Faculty of Biosciences, University of Heidelberg, Heidelberg, 69120, Germany; 3College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar*These authors contributed equally to this workCorrespondence: Wesam S Ahmed, Email wisamyejo@yahoo.com; wahmed@hbku.edu.qaPurpose: Biospecimen repositories and big data generated from clinical research are critically important in advancing patient-centered healthcare. However, ethical considerations arising from reusing clinical samples and health records for subsequent research pose a hurdle for big-data health research. This study aims to assess the public’s opinions in Jordan toward providing blanket consent for using biospecimens and health records in research.Participants and Methods: A cross-sectional study utilizing a self-reported questionnaire was carried out in different cities in Jordan, targeting adult participants. Outcome variables included awareness of clinical research, participation in clinical research, and opinions toward providing open access to clinical samples and records for research purposes. Descriptive analysis was utilized for reporting the outcome as frequency (percentages) out of the total responses. Univariate and multivariate logistic regression were used to investigate the association between independent variables and the outcome of interest.Results: A total of 1033 eligible participants completed the questionnaire. Although the majority (90%) were aware of clinical research, only 24% have ever participated in this type of research. About half (51%) agreed on providing blanket consent for the use of clinical samples, while a lower percentage (43%) agreed on providing open access to their health records. Privacy concerns and lack of trust in the researcher were cited as major barriers to providing blanket consent. Participation in clinical research and having health insurance were predictors for providing open access to clinical samples and records.Conclusion: The lack of public trust in Jordan toward data privacy is evident from this study. Therefore, a governance framework is needed to raise and maintain the public’s trust in big-data research that warrants the future reuse of clinical samples and records. As such, the current study provides valuable insights that will inform the design of effective consent protocols required in data-intensive health research.Keywords: biospecimens, health records, Jordan, open access, blanket consent, clinical research

Rana Abu-Farha,1 Karem H Alzoubi,2,3 Mai Rizik,1 Samar Karout,4 Rania Itani,4 Tareq Mukattash,3 Eman Alefishat5– 7 1Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, 11931, Jordan; 2Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates; 3Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 22110, Jordan; 4Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon; 5Department of Pharmacology, College of Medicine and Health Science, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; 6Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; 7Department Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, JordanCorrespondence: Eman Alefishat, Email Eman.alefishat@ku.ac.aeIntroduction: Home medication delivery service is a major service for the public. It reduces overcrowding and unnecessary visits to health centers. This study aims to investigate the public perception of home delivery of medication service in Jordan and evaluate factors affecting the use of this service.Methods: The study was conducted in March 2022 using an online survey. Participants were asked to fill out a validated questionnaire to evaluate their perception of home delivery of medication service.Results: Among the 1032 adult participated in this study, the majority reported that they had heard of home delivery of medication service (n = 832, 80.6%). However, only 30.9% of them have used this service before. Results showed that 71.4% of the participants (n = 737) believe that home delivery of medication service is more convenient and accessible than in-store drug refill. In addition, 65.6% of the participants (n = 677) believed that home delivery of medication service is suitable only for refill-prescription drugs (65.0%). The main pros of the service as perceived by the study participants were to serve sick patients, elderly, and disabled people (n = 822, 79.7%). In contrast, the inability of patients to build a professional relationship with pharmacists using home delivery of medications service was the most perceived con of this service (n = 627, 60.8%). Finally, regression analysis revealed that older participants, those with chronic diseases, and those who visit community pharmacies two times or more per month revealed higher use of the service (P = < 0.05).Conclusion: This study has shown that most participants showed positive perceptions toward the home delivery of medication services. However, participants believed that this service may decrease pharmacist’s patient contact time, thus affecting the quality of medication counseling. More comprehensive future studies are necessary to examine the financial aspects of such a service and its associated drawbacks.Keywords: community pharmacy, home delivery of medication, perception, public, Jordan

Sawsan Abuhammad,1 Omar F Khabour,2 Karem H Alzoubi,3,4 Shaher Hamaideh,5 Basheer Y Khassawneh,6 Amat Al-Khaleq O Mehrass,7 Baha F Alsmadi,6 Abdelrahman M Ababneh6 1Department of Maternal and Child Health, Faculty of Nursing, Jordan University of Science and Technology, Irbid, 22110, Jordan; 2Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, 22110, Jordan; 3Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates; 4Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 5Department of Community and Mental Health Nursing, Faculty of Nursing, The Hashemite University, Zarqa, 13133, Jordan; 6Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan; 7Department of Obstetric and Gynecology, Thamar University, Dhamar, YemenCorrespondence: Amat Al-Khaleq O Mehrass, Email Aykasem1@gmail.comAim: This study aims to determine health-related quality of life (HRQoL) that includes the physical and mental health of recovered patients of COVID-19 and examines the significant impact of variables such as period of infection, sample demographics characteristics, hospitalization past, and chronic disease past and the other variables on HRQoL of COVID-19-recovered patients.Methods: An exploratory, community-based, cross-sectional research layout was adopted, using an electronic self-reporting survey disseminated online to recovered COVID-19 patients in Jordan. Targeted COVID-19 patients were individuals who were 18 years old or above. They had a documented background of COVID-19 illness, as stated in the following inclusion requirements: Those who had not been formally proven to have been afflicted by COVID-19 were excluded.Results: The mean of the physical well-being of study participants during COVID-19 was M=68.00 (SD=6.95), representing medium physical well-being status. The mean of psychological well-being of study participants during COVID-19 was M=60.20 (SD=8.85), representing medium physical health. Multiple regression showed that female recovered patients who are not working, with a low level of income, married women, and who getting COVID-19 more than once are having lower health-related quality of life compared to other recovered patients.Conclusion: The HRQoL of COVID-19 patients was significantly impacted, independent of the period since hospitalization or rehabilitation. Policymakers and health workers should research strong ways to enhance the HRQoL of COVID-19 patients as soon as possible. Elderly patients and those who have been infected more than one time and being hospitalized have a greater probability of decreased HRQoL after infection.Keywords: mental health, physical health, COVID-19, recovered

Anan S Jarab,1,2 Walid A Al-Qerem,3 Hanan Walid Hamam,1 Karem H Alzoubi,4,5 Shrouq R Abu Heshmeh,1 Tareq L Mukattash,1 Eman Alefishat6– 8 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 22110, Jordan; 2College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates; 3Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, 11733, Jordan; 4Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates; 5Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 6Department of Pharmacology, College of Medicine and Health Science, Khalifa University of Science and Technology, Abu Dhabi, 127788, United Arab Emirates; 7Department Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, University of Jordan, Amman, 11942, Jordan; 8Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, 127788, United Arab EmiratesCorrespondence: Eman Alefishat, Department of Pharmacology, College of Medicine and Health Science, Khalifa University of Science and Technology, Abu Dhabi, 127788, United Arab Emirates, Tel +971 5 07293877, Email eman.alefishat@ku.ac.aeBackground: Poor adherence to heart failure (HF) medications represents a major barrier to achieve the desired health outcomes in those patients.Objective: To assess medication adherence and to explore the factors associated with medication non-adherence among patient with HF in Jordan.Methods: The current cross-sectional study was conducted at the outpatient cardiology clinics at two main hospitals in Jordan from August 2021 through April 2022. Variables including socio-demographics, biomedical variables, in addition to disease and medication characteristics were collected using medical records and custom-designed questionnaire. Medication adherence was assessed using the 4-item Morisky Medication Adherence Scale. Multinomial logistic regression analysis was performed to identify the factors that are significantly and independently associated with medication non-adherence.Results: Of the 427 participating patients, 92.5% had low to moderate medication adherence. Results of the regression analysis revealed that that patients who had higher education level (OR=3.36; 95% CI 1.08– 10.43; P=0.04) and were not suffering from medication-related side effects (OR=4.7; 95% CI 1.91– 11.5; P=0.001) had significantly higher odds of being in the moderate adherence group. Patients who were taking statins (OR=16.59; 95% CI 1.79– 153.98; P=0.01) or ACEIs/ ARBs (OR=3.95; 95% CI 1.01– 15.41; P=0.04) had significantly higher odds of being in the high adherence group. Furthermore, Patients who were not taking anticoagulants had higher odds of being in the moderate (OR=2.77; 95% CI 1.2– 6.46; P=0.02) and high (OR=4.11; 95% CI 1.27– 13.36; P=0.02) adherence groups when compared to patients who were taking anticoagulants.Conclusion: The poor medication adherence in the present study sheds the light on the importance of implementing intervention programs which focus on improving patients’ perception about the prescribed medications particularly for patients who have low educational levels, receive an anticoagulant, and do not receive a statin or an ACEI/ ARB.Keywords: heart failure, medication adherence, medication necessity, medication concerns, intervention, Jordan

Purpose The development and production of novel vaccine to prevent COVID-19 is an international imperative to human lives. For that purpose, clinical trials have to be carried out as per international ethical standards. The current study was undertaken to examine the willingness to participate in COVID-19 vaccine clinical trials and to determine factors that might affect their decision to participate. Patients and Methods A cross-sectional survey study was carried out among the public in Jordan. During the study period, a convenience sample of adults (aged 18 years or above) were asked to participate via an online self-administered survey that was designed to evaluate the willingness to participate in COVID-19 vaccine clinical trials and to determine factors affecting their decision to participate. Results Results showed that, among participants (n=1,287), 36.1% reported to be willing to participate in clinical trials of the vaccine. Additionally, a lower percentage (18.1%) were willing to allow their children to participate. Motivators that encourage participation were the desire to return to normal life (73.2%), followed by the desire to help in finding a treatment for COVID-19 infection (68.1%). Barriers towards the participation were not wanting to be challenged by the virus (54.7%), fear (40.7%), lack of time (40.4%), and mistrust in pharmaceutical companies (38.9%). Finally, results showed that higher educational level was associated with lower willingness to participate (P=0.001), whereas having a previous participation in clinical studies is associated with a significantly higher willingness to participate in COVID-19 vaccine clinical trials (P

Abdulsalam M Halboup,1 Karem H Alzoubi,2,3 Mohamed Izham Mohamed Ibrahim,4 Syed Azhar Syed Sulaiman,5 Yasmin Almahbashi,1 Shaima Al-Arifi,1 Sarah Mohammed,1 Gamil Othman1 1Department of Clinical Pharmacy and Pharmacy Practice University of Science and Technology, Sana’a, Yemen; 2Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates; 3Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan; 4Department of Clinical Pharmacy and Practice, Qatar University, Doha, Qatar; 5Discipline of Clinical Pharmacy, Universiti Sains Malaysia, Penang, MalaysiaCorrespondence: Gamil Othman, Department of Clinical Pharmacy and Pharmacy practice, University of Science and Technology, Sana’a, Yemen, Tel +‏ 967774960247, Email gamilqasem@yahoo.comPurpose: Patients’ awareness toward VTE and thromboprophylaxis is critical for medication adherence. This study aimed to evaluate the patient’s awareness and perception towards VTE and its prophylaxis and to assess patient’s satisfaction towards the information given by the medical staff.Participants and Methods: A cross-sectional survey was conducted among hospitalized patients who received VTE prophylaxis in public and private hospitals in Sana’a, Yemen. Besides sociodemographic variables, participants’ awareness and perception of VTE and its prophylaxis were evaluated. Variables’ association with VTE awareness were analyzed using univariable and multivariable logistic regression using SPSS.Results: A total of 396 of the hospitalized patients agreed to participate in the study, with 31% (n = 121) have ever heard about VTE. The multivariable logistic regression findings revealed that the participants who did not have a profession had OR = 17.182 (P < 0.001) of being unaware of VTE compared with those who had one. Participants who did not have a personal history of VTE had OR = 7.580 (P < 0.001) of being unaware of DVT/PE compared with the participants who had a personal history of VTE. Male participants had OR = 2.839 (P < 0.005) of being unaware of DVT/PE compared with female participants. Participants who were illiterate had OR = 2.832 (P < 0.022) of being unaware of DVT/PE compared with participants with a higher level of education.Conclusion: The study revealed lack of awareness and perception of VTE and its prophylaxis among hospitalized patients in Yemen. The patients who are unaware of the disease have wrong perception about their role in DVT prophylaxis. Patient’s education must be considered in healthcare setting to improve patient’s health outcomes.Keywords: anticoagulation, deep vein thrombosis, pulmonary embolism, patient’s knowledge, patient’s perception

Background The contact-tracing COVID-19 technology allows for tracing people that come in contact to individuals with COVID-19 wherever they are located. The number of tracing COVID-19 infection technology and devices is rapidly increasing. This has prompted many researchers to study the acceptability and ethical issues related to the implementation of such technology. Aim The purpose of this study was to determine the acceptability of COVID-19 contact-tracing technology and ethical issues of use. Methods A cross-sectional questionnaire-based study was used. The target population was Jordanian adults (>18 years). The survey was distributed to a convenience sample of 2000 general public in Jordan. Results The results found that the number of people who accept to use COVID-19 contact-tracing technology was 71.6%. However, the percentage of people who were using this technology was 37.8. The main ethical concerns for many of participants were privacy, voluntariness, and beneficence of the data. Only income and living area were predictors for acceptability and use of tracing technology (p≤ 0.01). Conclusion The majority of Jordanians accept the implementation of contact-tracing technology for COVID-19 infection. Among ethical concerns of the implementation of such technology were privacy, beneficence and voluntariness. Implications The results of this study would help in improving the state of science regarding acceptability to use contact-tracing technology for health purposes. Moreover, the present findings provide evidence of predictors of acceptance and ethical concerns among Jordanian population about COVID-19 contact-tracing technology.

Purpose Recruitment of adequate numbers of research participants is important for advancement in biomedical fields. Awareness and knowledge of the population about biomedical research are expected to enhance willingness to participate in such research. Therefore, in the current study, participants' awareness, knowledge, and willingness to participate in scientific research in Jordan were examined. Methods This was a survey-based, cross-sectional study conducted from December 2019 to February 2020 among the public in Jordan. After written informed consent had been obtained from study participants, a structured questionnaire was used to survey research participants. The final questionnaire contained three parts: part I was about demographics and general information, part II assessed participants' awareness and willingness to participate in biomedical research, and part III assessed participants' knowledge about biomedical research studies. Results A total of 2,000 subjects agreed to participate, of which 67.4% were female (n=1339). More than half the respondents were aware of biomedical research (58.6%), of which 18.1% had previously participated in biomedical research. In addition, 55.5% reported that they were willing to participate in biomedical research, while a lower proportion (31.1%) were willing to volunteer in a clinical trial. The overall knowledge of participants about biomedical research was deemed moderate (total score 12.9 out of 20). Finally, willingness to participate in biomedical research was associated with being male, being married, having a biomedicine-related degree, and higher knowledge score. Conclusion A majority of Jordanians had moderate levels of awareness and knowledge about biomedical research. Such factors as sex, type of education, and knowledge contribute to willingness to participate in biomedical research.

Purpose The development and production of novel vaccine to prevent COVID-19 is an international imperative to human lives. For that purpose, clinical trials have to be carried out as per international ethical standards. The current study was undertaken to examine the willingness to participate in COVID-19 vaccine clinical trials and to determine factors that might affect their decision to participate. Patients and Methods A cross-sectional survey study was carried out among the public in Jordan. During the study period, a convenience sample of adults (aged 18 years or above) were asked to participate via an online self-administered survey that was designed to evaluate the willingness to participate in COVID-19 vaccine clinical trials and to determine factors affecting their decision to participate. Results Results showed that, among participants (n=1,287), 36.1% reported to be willing to participate in clinical trials of the vaccine. Additionally, a lower percentage (18.1%) were willing to allow their children to participate. Motivators that encourage participation were the desire to return to normal life (73.2%), followed by the desire to help in finding a treatment for COVID-19 infection (68.1%). Barriers towards the participation were not wanting to be challenged by the virus (54.7%), fear (40.7%), lack of time (40.4%), and mistrust in pharmaceutical companies (38.9%). Finally, results showed that higher educational level was associated with lower willingness to participate (P=0.001), whereas having a previous participation in clinical studies is associated with a significantly higher willingness to participate in COVID-19 vaccine clinical trials (P